IPO

Amwill Healthcare Limited IPO

BSE SME

Listed On: Feb 12, 2025 at ₹ 88.85

₹ 266400 /2400 Shares
*Min Investment

Check Allotment

05 Feb, 2025

Open Date

07 Feb, 2025

Close Date

10 Feb, 2025

Allotment Date

12 Feb, 2025

Listing Date
Amwill Healthcare IPO Issue Details
  • Issue Price ₹105-111 per equity share
  • Face Value ₹10 Per Equity Share
  • Total Issue Size 54,03,600 shares(aggregating up to ₹59.98 crore)
  • Fresh Share 44,03,600 shares(aggregating up to ₹48.88 crore)
  • Offer For Sale 10,00,000 shares(aggregating up to ₹11.1 crore)
  • Listing at BSE SME
  • List Price 88.85
  • Listing Date 2025-02-12
  • Lead Manager Unicon Capital Services Private Ltd
  • Registrar Bigshare Services Pvt Ltd
Market Lot Size

Investors can bid for a minimum of 1200 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

ApplicationLotsSharesAmount
Retail (min)11200₹1,33,200
Retail(max)11200₹1,33,200
NII (min) 22,400₹2,66,400
Amwill Healthcare IPO Reservation

Amwill Healthcare IPO offers total 54,03,600 shares. Out of which 10,26,000 (18.99%) allocated to QIB, 20,53,200 (38%) allocated to NII,20,53,200 (38%) allocated to RII, NA (NA%) allocated to employees and - (NA%) allocated to Anchor investors.

Investor CategoryShares OfferedMaximum Allottees
Anchor Investor Shares Offered- (NA%)
Market Maker Shares Offered2,71,200 (5.02%)
QIB Shares Offered10,26,000 (18.99%)
NII (HNI) Shares Offered20,53,200 (38%)
Retail Shares Offered20,53,200 (38%)
Total Shares Offered54,03,600 (100%)
Amwill Healthcare IPO Documents
DRHP
RHP
Amwill Healthcare IPO Details


Amwill Healthcare Limited IPO is an SME IPO, priced at ₹105-111 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the BSE SME platform. The IPO comprises a total issue of 54,03,600 equity shares, aggregating up to ₹59.98 crores..

The IPO bidding window is open from Feb 5, 2025 to Feb 7, 2025. The allotment is expected to be finalized on Feb 10, 2025, and the tentative listing date is Feb 12, 2025.

The minimum lot size for Retail investors is 1200 shares, with a minimum investment of ₹1,33,200. For HNIs, the minimum application size is 2 lots , amounting to ₹ 2,66,400.

Unicon Capital Services Private Ltd is acting as the lead manager to the issue. The registrar of the IPO is Bigshare Services Pvt Ltd, and Globalworth Securities Limited will act as the market maker for this issue.

Read More
Amwill Healthcare IPO Subscription Analysis And Details
Retail
4.77x
Total
5.73x
As onQIB / NIIRetailTotal
Shares Offered / Reserved10,26,000 / 20,53,20020,53,20051,32,400
Day 1 05-02-25 06:00 PM
2.19 / 0.51 x1.00 x1.04 x
Day 2 06-02-25 06:00 PM
2.19 / 0.53 x1.92 x5.73 x
Day 3 07-02-25 06:00 PM
7.80 / 5.66 x4.77 x5.73 x
Total No of Applications
9,413
Amwill Healthcare Valuations
EPS Pre IPO ₹8.04/-
EPS Post IPO ₹6.52/-
P/E Pre IPO 13.81
P/E Post IPO 17.04
ROE 73.06%
ROCE 94.16%
RoNW 73.06%
PAT Margin 28.53
Price to Book Value 10.09
Amwill Healthcare Company Financials
In Crs.
In Cr.
31-Mar-2431-Mar-2331-Mar-22
Assets18.9812.396.59
Revenue44.2830.2827.62
Profit After Tax12.543.112.57
Net Worth17.164.61.49
Reserves & Surplus17.114.571.46
About Amwill Healthcare Company

Incorporated in August 2017, Amwill Health Care Limited is a derma-cosmetic development firm that partners with contract manufacturers, distributors, and third-party product development agencies. This partnership has helped the company improve its manufacturing, packaging, and distribution capacity.

The Company's product portfolio is categorized into two segments, namely,
Generic dermatological solutions development and

Formulation of targeted solutions for dermatological conditions.
The company markets its products in Karnataka, Andhra Pradesh and Telangana, focusing on strengthening its presence before entering new markets to build a customer base.

The company develops products for dermatological disorders, including acne, fungal infections, anti-ageing, histaminic, periorbital hyperpigmentation, scabies, perspiration, trichology, and vitiligo.

As of April 30, 2024, the company has 31 employees in its marketing team.

As of April 30, 2024, the company has 59 employees on payroll.

Read More
Amwill Healthcare - Promoter(s)

Anand Gandhi

Tarun Gandhi

Pre Issue Share Holding : 97.00%

Post Issue Share Holding : %

Amwill Healthcare IPO - Issue Objectives
1

Funding of working capital requirements of the Company

2

Marketing and brand-building activities

3

General corporate purposes

Amwill Healthcare IPO - Peers Comparison
Company NameEPS (Basic)EPS (Diluted)NAV (per share) (Rs)P/E (x)RoNW (%)P/BV RatioFinancial statements
Amwill Healthcare Limited8.048.0411N/A73.0610.09Standalone
Vaishali Pharma Limited0.680.6439.9726.451.68N/AStandalone
Trident Lifeline Ltd6.136.1345.8145.0613.3714Standalone

Notes:

  1. The P/E Ratio has been computed based on the closing market price of equity shares on the NSE/BSE website on January 07, 2025, divided by the Diluted EPS.
  2. Net Profit after tax, as restated divided by Average Net-worth, as restated (Net worth includes share capital and reserves and surplus).
  3. NAV is computed as the closing net worth divided by the outstanding equity shares.
Contact Details

Amwill Healthcare

No. 157, 1st Floor, 2nd Main, r, 2nd Main, 3rd Cross Chamrajpet, Bangalore – 560018

+91 8043026281

amwill@amwillhealthcare.com

https://www.amwillhealthcare.com/

Registrar Contact Details

Bigshare Services Pvt Ltd

+91-22-6263 8200

ipo@bigshareonline.com

https://ipo.bigshareonline.com/ipo_status.html